Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Martin Risch and Nadia Wohlwend.
Martin Risch
Connection Strength
1.084
Nadia Wohlwend
  1. Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study. J Clin Med. 2020 Dec 09; 9(12).
    View in: PubMed
    Score: 0.229
  2. Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study. Clin Chem Lab Med. 2020 11 19; 59(2):e49-e51.
    View in: PubMed
    Score: 0.229
  3. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation. Biomed Res Int. 2020; 2020:9878453.
    View in: PubMed
    Score: 0.228
  4. Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study. Clin Chem Lab Med. 2020 08 31; 58(12):2131-2140.
    View in: PubMed
    Score: 0.225
  5. SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021-Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing. Microorganisms. 2021 Mar 25; 9(4).
    View in: PubMed
    Score: 0.059
  6. Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies. Dis Markers. 2021; 2021:8810196.
    View in: PubMed
    Score: 0.058
  7. Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational study. Swiss Med Wkly. 2020 10 05; 150:w20361.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.